UK markets closed

Xilio Therapeutics, Inc. (XLO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0200-0.0600 (-5.56%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.23-0.4-1.39-0.94
Low estimate-0.66-0.57-2.16-1.89
High estimate0.2-0.24-0.630.01
Year ago EPS-0.7-0.61-2.78-1.39
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts1122
Avg. Estimate30MN/A15M37.5M
Low estimate30MN/AN/AN/A
High estimate30MN/A30M75M
Year ago salesN/AN/AN/A15M
Sales growth (year/est)N/AN/AN/A150.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.87-0.81-0.64-0.11
Actual EPS-0.7-0.61-0.64-0.62
Difference0.170.20-0.51
Surprise %19.50%24.70%0.00%-463.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.23-0.4-1.39-0.94
7 days ago-0.23-0.4-1.39-0.94
30 days ago-0.48-0.43-1.47-0.96
60 days ago-0.47-0.45-1.75-1.38
90 days ago-0.63-0.88-3.1-2.55
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1111
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesXLOIndustrySector(s)S&P 500
Current qtr.67.10%N/AN/AN/A
Next qtr.34.40%N/AN/AN/A
Current year50.00%N/AN/AN/A
Next year32.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A